Skip to main content
NVDA-2.17%AAPL+2.05%GOOGL-0.45%MSFT-0.96%AMZN-0.41%TSM-2.03%SPCX+1.57%AVGO-1.56%META+0.56%TSLA-1.59%SKHY-4.70%MU-3.75%BRK-B+0.21%LLY+0.35%JPM-0.22%AMD-2.35%WMT+1.20%V+0.02%XOM+0.74%ASMLa-3.02%JNJ+1.11%INTC-4.62%MA-0.35%0700.HK-1.94%ORCL-2.80%1398.HK+0.79%BAC+0.34%ABBV+0.60%CSCO-0.16%CVX+0.42%COST+1.01%LRCX-4.00%KO+1.55%CAT-0.98%AMAT-2.62%0005.HK-0.78%AP2d-1.87%UNH+0.67%DELL-2.07%HSBA.L-0.94%MS-0.05%PG+0.19%GE-0.12%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-1.09%HD-0.91%GS-0.62%0939.HK+1.66%NZDJPY-2.69%AUDJPY-1.95%CHFJPY-1.68%NZDCAD-1.45%EURNZD+1.39%GBPJPY-1.38%NZDUSD-1.37%USDJPY-1.36%EURJPY-1.36%GBPNZD+1.32%CADJPY-1.26%NZDCHF-1.04%USDNOK+0.90%USDZAR+0.88%AUDNZD+0.77%USDSEK+0.75%EURNOK+0.73%AUDCAD-0.72%EURZAR+0.70%AUDDKK-0.63%USDMXN+0.63%CHFNOK+0.62%GBPZAR+0.61%EURAUD+0.61%AUDUSD-0.60%AUDSGD-0.58%EURSEK+0.58%GBPAUD+0.56%NOKJPY-0.52%USDTHB+0.47%CHFSEK+0.47%USDPLN+0.42%NZDSGD-0.42%GBPTRY+0.41%CADCHF+0.41%USDCHF+0.34%GBPHKD+0.32%EURCHF+0.32%GBPCHF+0.29%GBPMXN-0.28%AUDCHF-0.27%EURPLN+0.24%USDSGD+0.22%EURHKD-0.19%USDDKK+0.18%USDILS+0.16%SGDJPY+0.16%GBPCAD-0.14%USDTRY+0.11%EURCAD-0.10%AUDNOK+0.10%USDCAD-0.08%EURCNH-0.08%USDCNH+0.08%CHFSGD-0.06%EURSGD+0.05%GBPSGD-0.04%EURGBP+0.04%PLNJPY-0.04%USDCOP-0.04%NZDMXN-0.04%GBPUSD-0.03%EURCZK-0.01%EURUSD-0.01%EURDKK0.00%USDHKD0.00%XPTUSD-4.58%HG1-4.13%XAGUSD-4.05%GAGUSD-4.05%COFFEE-2.89%UKOIL+2.81%USOIL+2.61%W1-0.96%C1-0.85%GAUUSD-0.72%XAUUSD-0.71%SUGAR+0.60%BTCUSD-1.61%ETHUSD-1.65%USDTUSD-0.02%XRPUSD-2.35%SOLUSD-1.99%TRXUSDT-0.12%ZECUSDT-5.99%DOGEUSD-2.74%XMRUSDT-1.76%LINKUSD-0.98%XLMUSD-1.89%BCHUSDT-8.60%LTCUSD-1.71%UNIUSD-4.14%TONUSD+24.88%HBARUSDT-2.02%SUIUSD-2.75%TAOUSDT-4.38%AAVEUSD-2.78%DOTUSDT-2.72%ICPUSDT-0.83%ONDOUSDT-2.59%WLDUSDT-2.67%ATOMUSDT-2.54%ARBUSDT-0.76%JUPUSDT-2.96%INJUSDT-3.55%STXUSDT-3.43%FETUSDT-3.15%TIAUSDT-1.39%SEIUSDT-3.91%PYTHUSDT-0.95%IMXUSDT-3.06%WIFUSDT-4.40%GRTUSDT-3.53%OPUSDT-3.00%IOTAUSDT-3.25%POLUSDT-6.32%AXSUSDT-2.47%FARTCOINUSDT-2.20%EOSUSDT-1.42%DYDXUSDT-0.52%ORDIUSDT-0.24%GALAUSDT-4.21%NOTUSDT-0.68%RONINUSDT-2.64%NVDA-2.17%AAPL+2.05%GOOGL-0.45%MSFT-0.96%AMZN-0.41%TSM-2.03%SPCX+1.57%AVGO-1.56%META+0.56%TSLA-1.59%SKHY-4.70%MU-3.75%BRK-B+0.21%LLY+0.35%JPM-0.22%AMD-2.35%WMT+1.20%V+0.02%XOM+0.74%ASMLa-3.02%JNJ+1.11%INTC-4.62%MA-0.35%0700.HK-1.94%ORCL-2.80%1398.HK+0.79%BAC+0.34%ABBV+0.60%CSCO-0.16%CVX+0.42%COST+1.01%LRCX-4.00%KO+1.55%CAT-0.98%AMAT-2.62%0005.HK-0.78%AP2d-1.87%UNH+0.67%DELL-2.07%HSBA.L-0.94%MS-0.05%PG+0.19%GE-0.12%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-1.09%HD-0.91%GS-0.62%0939.HK+1.66%NZDJPY-2.69%AUDJPY-1.95%CHFJPY-1.68%NZDCAD-1.45%EURNZD+1.39%GBPJPY-1.38%NZDUSD-1.37%USDJPY-1.36%EURJPY-1.36%GBPNZD+1.32%CADJPY-1.26%NZDCHF-1.04%USDNOK+0.90%USDZAR+0.88%AUDNZD+0.77%USDSEK+0.75%EURNOK+0.73%AUDCAD-0.72%EURZAR+0.70%AUDDKK-0.63%USDMXN+0.63%CHFNOK+0.62%GBPZAR+0.61%EURAUD+0.61%AUDUSD-0.60%AUDSGD-0.58%EURSEK+0.58%GBPAUD+0.56%NOKJPY-0.52%USDTHB+0.47%CHFSEK+0.47%USDPLN+0.42%NZDSGD-0.42%GBPTRY+0.41%CADCHF+0.41%USDCHF+0.34%GBPHKD+0.32%EURCHF+0.32%GBPCHF+0.29%GBPMXN-0.28%AUDCHF-0.27%EURPLN+0.24%USDSGD+0.22%EURHKD-0.19%USDDKK+0.18%USDILS+0.16%SGDJPY+0.16%GBPCAD-0.14%USDTRY+0.11%EURCAD-0.10%AUDNOK+0.10%USDCAD-0.08%EURCNH-0.08%USDCNH+0.08%CHFSGD-0.06%EURSGD+0.05%GBPSGD-0.04%EURGBP+0.04%PLNJPY-0.04%USDCOP-0.04%NZDMXN-0.04%GBPUSD-0.03%EURCZK-0.01%EURUSD-0.01%EURDKK0.00%USDHKD0.00%XPTUSD-4.58%HG1-4.13%XAGUSD-4.05%GAGUSD-4.05%COFFEE-2.89%UKOIL+2.81%USOIL+2.61%W1-0.96%C1-0.85%GAUUSD-0.72%XAUUSD-0.71%SUGAR+0.60%BTCUSD-1.61%ETHUSD-1.65%USDTUSD-0.02%XRPUSD-2.35%SOLUSD-1.99%TRXUSDT-0.12%ZECUSDT-5.99%DOGEUSD-2.74%XMRUSDT-1.76%LINKUSD-0.98%XLMUSD-1.89%BCHUSDT-8.60%LTCUSD-1.71%UNIUSD-4.14%TONUSD+24.88%HBARUSDT-2.02%SUIUSD-2.75%TAOUSDT-4.38%AAVEUSD-2.78%DOTUSDT-2.72%ICPUSDT-0.83%ONDOUSDT-2.59%WLDUSDT-2.67%ATOMUSDT-2.54%ARBUSDT-0.76%JUPUSDT-2.96%INJUSDT-3.55%STXUSDT-3.43%FETUSDT-3.15%TIAUSDT-1.39%SEIUSDT-3.91%PYTHUSDT-0.95%IMXUSDT-3.06%WIFUSDT-4.40%GRTUSDT-3.53%OPUSDT-3.00%IOTAUSDT-3.25%POLUSDT-6.32%AXSUSDT-2.47%FARTCOINUSDT-2.20%EOSUSDT-1.42%DYDXUSDT-0.52%ORDIUSDT-0.24%GALAUSDT-4.21%NOTUSDT-0.68%RONINUSDT-2.64%
ZY

Zymeworks Inc. (ZYME)

NASDAQ • Healthcare

$27.15
-$0.96 (-3.4%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$27.81
Previous Close$27.15
Day Range$27.08 - $28.09
Avg. Volume (3M)711.6K
Market Cap$1.9B
52 Week Range
$14.88$31.34
Next EarningsIn 56 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$4.5M100%
Gross Profitminus cost of goods$4.5M100%

Fundamentals & Financials

Revenue (TTM)
$37.1M
Net Income (TTM)
-$149.9M
EPS (TTM)
-$2.02
ROA (TTM)
-37.78%
Current Ratio
6.32

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-57.1%Q1 2026-$0.55
-490.0%Q2 2026-$0.59
-7.9%Q3 2026-$0.62
Next

Nov 5

in 56 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Zymeworks Inc.

Zymeworks Inc. is a NASDAQ-listed biotechnology company in the healthcare sector that develops biological therapies for cancer and remains in the clinical development stage. Its work centers on antibody-based drug candidates, and it generated $106.0 million of revenue in FY2025.

Name
Zymeworks Inc.
CEO
Kenneth H. Galbraith
Website
www.zymeworks.com
Industry
Healthcare
Year Founded
2003
Employees
231

Today's Snapshot

AI-generated

ZYME closed 3.4% lower at 27.15.

Trading Volume

Below 10d avg (649.8K)

382.8K

vs S&P 500 Today

Underperforming Market

-2.94%

Updated: September 10, 2026 at 12:29 UTC

Technical Indicators

3 Buy3 Neutral2 Sell
ZYME’s profile reflects a constructive longer-term trend with signs of a short-term pullback. The ADX is strong, supporting a prevailing trend, while price sits below the short 10–20 day averages but above the 50/100/200 day averages, indicating a recent dip inside a broader uptrend. Momentum readings are mostly neutral, with RSI and MACD near hold, and CCI muted, so upside conviction is not overwhelming. Volatility is elevated by ATR and on-balance volume shows recent distribution, and the classic pivot sits above the current price. Technical takeaway: Buy — longer-term trend remains constructive despite a short-term retracement.
All signals
  • EMA (5 indicators)$24.11 - $28.55
    Buy
  • RSI (14)49.50
    Neutral
  • Stochastic %K (14, 3, 3)44.95
    Neutral
  • MACD Level (12, 26)1.10
    Neutral

Peers & Related Assets

SYRESpyre Therapeutics, Inc.
$86.93-4.3%
IMNMImmunome, Inc.
$26.12-2.6%
TRVITrevi Therapeutics, Inc.
$16.64-1.1%
BCRXBioCryst Pharmaceuticals, Inc.
$8.81-2.9%
NTLAIntellia Therapeutics, Inc.
$12.21-4.2%
MAZEMaze Therapeutics, Inc.
$24.58-6.8%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.